Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review

Mantle cell lymphoma (MCL) accounts for about 5% of all lymphomas. Its clinical and histological features are heterogeneous. After a frequently good initial response, the disease generally and repeatedly relapses and finally the outcome is poor. Particularly severe is the prognosis of the rare occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannina, Donato, Loteta, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534293/
https://www.ncbi.nlm.nih.gov/pubmed/28791187
http://dx.doi.org/10.1155/2017/9583257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534293/
https://www.ncbi.nlm.nih.gov/pubmed/28791187
http://dx.doi.org/10.1155/2017/9583257

Ejemplares similares